Cargando…
Heart Transplantation in Adriamycin-Associated Cardiomyopathy in the Contemporary Era of Advanced Heart Failure Therapies
BACKGROUND: Adriamycin-associated cardiomyopathy (ACM) can lead to end-stage heart failure requiring advanced heart failure therapies. OBJECTIVES: This study sought to provide post–cardiac transplant survival data in patients with ACM in the contemporary era of mechanical circulatory support and car...
Autores principales: | Ramu, Bhavadharini, Masotti, Maria, Tedford, Ryan J., Cogswell, Rebecca J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352281/ https://www.ncbi.nlm.nih.gov/pubmed/34396337 http://dx.doi.org/10.1016/j.jaccao.2021.02.010 |
Ejemplares similares
-
Heart Transplantation for Adriamycin Cardiomyopathy: The Plural of Anecdote and the Power of Registries
por: Kittleson, Michelle M.
Publicado: (2021) -
Shielding the Heart: Preload Reduction Therapies in Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2023) -
Contemporary challenges in the management of advanced heart failure
por: Gašparović, Hrvoje, et al.
Publicado: (2014) -
Advanced heart failure: a contemporary approach
por: Chun, Kyeong-Hyeon, et al.
Publicado: (2023) -
Assessment of U.S. heart transplantation equity as a function of race: Observational analyses of the OPTN database
por: Cogswell, Rebecca, et al.
Publicado: (2022)